id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-E-0334-0009,FDA,FDA-2010-E-0334,FDA\CDER to U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2012-12-27T15:16:22Z,,0,0,090000648119c5b0
FDA-2010-E-0334-0008,FDA,FDA-2010-E-0334,Determination of Regulatory Review Period for Purposes of Patent Extension; KALBITOR; Correction,Notice,Correction,2012-06-08T04:00:00Z,2012,6,2012-06-08T04:00:00Z,,2012-06-08T13:16:34Z,2012-13902,0,0,090000648103c19d
FDA-2010-E-0334-0007,FDA,FDA-2010-E-0334,"(AL) Lando & Anastasi, LLP - Letter",Other,Letter(s),2012-06-05T04:00:00Z,2012,6,2012-06-05T04:00:00Z,,2012-06-05T22:01:00Z,,0,0,09000064810360dd
FDA-2010-E-0334-0006,FDA,FDA-2010-E-0334,Determination of Patent Extension Regulatory Review Period: Kalbitor,Notice,General Notice,2012-05-02T04:00:00Z,2012,5,2012-05-02T04:00:00Z,2012-07-03T03:59:59Z,2012-05-02T20:22:20Z,2012-10518,0,0,090000648100383f
FDA-2010-E-0334-0005,FDA,FDA-2010-E-0334,FDA\CDER to U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-04-18T04:00:00Z,2012,4,2012-04-18T04:00:00Z,,2012-04-18T11:56:41Z,,0,0,0900006480ff32b5